These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31974595)

  • 1. Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model.
    Du HL; Zhai AD; Yu H
    Mol Med Rep; 2020 Feb; 21(2):927-935. PubMed ID: 31974595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine alleviates LPS‑induced acute lung injury via regulation of the p38/HO‑1 pathway.
    Sun Y; Xia Y; Liu X; Liu J; He W; Ye H; Yuan X
    Mol Med Rep; 2020 Sep; 22(3):2442-2450. PubMed ID: 32705282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner.
    Huang XT; Liu W; Zhou Y; Hao CX; Zhou Y; Zhang CY; Sun CC; Luo ZQ; Tang SY
    Int J Mol Med; 2019 Dec; 44(6):2213-2222. PubMed ID: 31661121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
    Luo Y; Che W; Zhao M
    Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone Attenuates LPS-induced Acute Lung Injury through Inhibition of NF-κB, COX-2, and Pro-inflammatory Mediators.
    Al-Harbi NO; Imam F; Al-Harbi MM; Ansari MA; Zoheir KM; Korashy HM; Sayed-Ahmed MM; Attia SM; Shabanah OA; Ahmad SF
    Immunol Invest; 2016 May; 45(4):349-69. PubMed ID: 27104958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA‑17 contributes to the suppression of the inflammatory response in lipopolysaccharide‑induced acute lung injury in mice via targeting the toll‑like receptor 4/nuclear factor‑κB pathway.
    Fu S
    Int J Mol Med; 2020 Jul; 46(1):131-140. PubMed ID: 32626914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway.
    Wu X; Lin L; Wu H
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22664. PubMed ID: 33140555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine ameliorates LPS induced acute lung injury via GSK-3β/STAT3-NF-κB signaling pathway in rats.
    Zhang H; Sha J; Feng X; Hu X; Chen Y; Li B; Fan H
    Int Immunopharmacol; 2019 Sep; 74():105717. PubMed ID: 31254953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
    Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
    Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgolide C attenuates lipopolysaccharide‑induced acute lung injury by inhibiting inflammation via regulating the CD40/NF‑κB signaling pathway.
    Zhang R; Guo N; Yan G; Wang Q; Gao T; Zhang B; Hou N
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linarin prevents LPS‑induced acute lung injury by suppressing oxidative stress and inflammation via inhibition of TXNIP/NLRP3 and NF‑κB pathways.
    Han X; Wu YC; Meng M; Sun QS; Gao SM; Sun H
    Int J Mol Med; 2018 Sep; 42(3):1460-1472. PubMed ID: 29845284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose dexamethasone alleviates lipopolysaccharide-induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors.
    Wang XQ; Zhou X; Zhou Y; Rong L; Gao L; Xu W
    Respirology; 2008 Nov; 13(6):772-80. PubMed ID: 18657064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurine enhances the protective effect of Dexmedetomidine on sepsis-induced acute lung injury via balancing the immunological system.
    Zhao W; Jia L; Yang HJ; Xue X; Xu WX; Cai JQ; Guo RJ; Cao CC
    Biomed Pharmacother; 2018 Jul; 103():1362-1368. PubMed ID: 29864919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17 antagonist attenuates lung inflammation through inhibition of the ERK1/2 and NF-κB pathway in LPS-induced acute lung injury.
    Li TJ; Zhao LL; Qiu J; Zhang HY; Bai GX; Chen L
    Mol Med Rep; 2017 Aug; 16(2):2225-2232. PubMed ID: 28656298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenuigenin ameliorates acute lung injury by inhibiting NF-κB and MAPK signalling pathways.
    Lv H; Zhu C; Liao Y; Gao Y; Lu G; Zhong W; Zheng Y; Chen W; Ci X
    Respir Physiol Neurobiol; 2015 Sep; 216():43-51. PubMed ID: 25930113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
    Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
    J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine and Magnesium Sulfate: A Good Combination Treatment for Acute Lung Injury?
    Güzel A; Doğan E; Türkçü G; Kuyumcu M; Kaplan İ; Çelik F; Yıldırım ZB
    J Invest Surg; 2019 Jun; 32(4):331-342. PubMed ID: 29359990
    [No Abstract]   [Full Text] [Related]  

  • 20. PCTR1 improves pulmonary edema fluid clearance through activating the sodium channel and lymphatic drainage in lipopolysaccharide-induced ARDS.
    Zhang PH; Han J; Cao F; Liu YJ; Tian C; Wu CH; Smith FG; Hao Y; Jin SW
    J Cell Physiol; 2020 Dec; 235(12):9510-9523. PubMed ID: 32529661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.